Tapewire

Nasdaq · USD

SGHT

Sight Sciences, Inc.

Export transactions ↓
Tapewire entity
5537
SEC CIK
0001531177
Parsed reports
225

Last 12 months

Inside the activity.

2 purchase rows · 38 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202503
Dec 202511
Jan 2026016
Feb 202600
Mar 202600
Apr 202606
May 202601
Jun 202610
Jul 202606
Aug 202600
Sep 202600
Oct 202605

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 08, 2023 Filed Jun 12, 2023 21:41 UTC GrantCommon Stock 15,094 $0.00 $0.00
Disclosure

SEC source: 0000899243-23-015382 · doc4.xml · nonDerivative · entry 3

Larsen-Becker Brenda Jane · CIK 0001913647 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,679

F4 · shares: Reflects a grant of RSUs made to the Reporting Person under the Issuer's Non-Employee Director Compensation Program. Each RSU represents a contingent right to receive one share of Common Stock. The number of RSUs granted is equal to approximately $120,000 of shares of Common Stock as determined by the closing price on the grant date, June 8, 2023. The RSUs vest on the earlier of June 8, 2024 and the date of the Issuer's 2024 annual meeting of stockholders, subject to the Reporting Person's continued service as a director on the Company's board of directors through such vesting date.

Read SEC document
June 08, 2023 Filed Jul 3, 2023 22:04 UTC GrantCommon Stock 30,189 $0.00 $0.00
Disclosure

SEC source: 0000899243-23-016838 · doc4.xml · nonDerivative · entry 1

Mazzacco Catherine · CIK 0001967722 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · shares: Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's Non-Employee Director Compensation Program. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The number of RSUs granted is equal to approximately $240,000 of shares of Common Stock as determined by the closing price on the grant date, June 8, 2023. The RSUs vest in substantially equal installments on each of June 8, 2024, 2025, and 2026, subject to the Reporting Person's continued service as a director on the Company's board of directors through each such vesting date.

Read SEC document
June 08, 2023 Filed Nov 16, 2023 22:35 UTC Amendment
Encrantz StaffanDirector · 10% owner
GrantCommon Stock 15,094 $0.00 $0.00
Disclosure

SEC source: 0000950170-23-064579 · ownership.xml · nonDerivative · entry 2

Encrantz Staffan · CIK 0001870875 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,034

F2 · shares: Reflects a grant of RSUs made to the Reporting Person under the Program. Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest on the earlier of June 8, 2024 and the date of the Issuer's 2024 annual meeting of stockholders, subject to the Reporting Person's continued service as a director on the Issuer's board of directors through such vesting date.

Read SEC document
June 08, 2023 Filed Nov 16, 2023 22:35 UTC Amendment
Encrantz StaffanDirector · 10% owner
GrantCommon Stock 11,940 $0.00 $0.00
Disclosure

SEC source: 0000950170-23-064579 · ownership.xml · nonDerivative · entry 1

Encrantz Staffan · CIK 0001870875 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,940

F1 · shares: Reflects the vesting in full of 11,940 restricted stock units ("RSUs") granted to the Reporting Person on June 8, 2022 under the Issuer's Non-Employee Director Compensation Program (the "Program"), as reported in Table II on the Reporting Person's Form 4 filed with the Securities and Exchange Commission on August 5, 2022. Each RSU represented a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock").

Read SEC document
May 09, 2023 Filed May 12, 2023 01:55 UTC
Bauerlein AlisonSee Remarks
GrantStock Option (Right to Buy) · Derivative 71,800 $0.00 Strike: $10.10 $0.00
Disclosure

SEC source: 0000899243-23-012788 · doc4.xml · derivative · entry 2

Bauerlein Alison · CIK 0001596080 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,800

Underlying: Common Stock · 71,800 shares

Expires 2033-05-09

F2 · shares: Reflects a grant of stock options ("Options") made to the Reporting Person under the 2021 Plan. The Options vest and become exercisable as to 25% of the underlying shares on April 3, 2024, and as to the remainder of such shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date, such that all such Options shall be fully vested and exercisable on April 3, 2027.

F2 · derivative.exercise_date: Reflects a grant of stock options ("Options") made to the Reporting Person under the 2021 Plan. The Options vest and become exercisable as to 25% of the underlying shares on April 3, 2024, and as to the remainder of such shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date, such that all such Options shall be fully vested and exercisable on April 3, 2027.

Read SEC document
May 09, 2023 Filed May 12, 2023 01:55 UTC
Bauerlein AlisonSee Remarks
GrantCommon Stock 103,000 $0.00 $0.00
Disclosure

SEC source: 0000899243-23-012788 · doc4.xml · nonDerivative · entry 1

Bauerlein Alison · CIK 0001596080 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · shares: Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's 2021 Incentive Award Plan (the "2021 Plan"). The RSUs vest in four equal annual installments commencing May 15, 2024 and continuing through May 15, 2027, subject to the Reporting Person's continued service to the Issuer through each vesting date. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share. The RSUs have no expiration date.

Read SEC document
March 16, 2023 Filed Mar 21, 2023 06:15 UTC
Park Sam BoongChief Operating Officer
GrantStock Option (Right to Buy) · Derivative 69,100 $0.00 Strike: $9.78 $0.00
Disclosure

SEC source: 0000899243-23-009243 · doc4.xml · derivative · entry 2

Park Sam Boong · CIK 0001871706 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 69,100

Underlying: Common Stock · 69,100 shares

Expires 2033-03-16

F3 · shares: Reflects a grant of stock options ("Options") made to the Reporting Person under the 2021 Plan. The Options vest and become exercisable in 48 equal monthly installments with the first installment vesting commencing on January 1, 2023 through January 1, 2027, subject to the Reporting Person's continued service to the Issuer through each vesting date.

F3 · derivative.exercise_date: Reflects a grant of stock options ("Options") made to the Reporting Person under the 2021 Plan. The Options vest and become exercisable in 48 equal monthly installments with the first installment vesting commencing on January 1, 2023 through January 1, 2027, subject to the Reporting Person's continued service to the Issuer through each vesting date.

Read SEC document
March 16, 2023 Filed Mar 21, 2023 06:15 UTC
Park Sam BoongChief Operating Officer
GrantCommon Stock 54,100 $0.00 $0.00
Disclosure

SEC source: 0000899243-23-009243 · doc4.xml · nonDerivative · entry 1

Park Sam Boong · CIK 0001871706 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,424

F1 · shares: Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's 2021 Incentive Award Plan (the "2021 Plan"). The RSUs vest in four equal annual installments from January 15, 2024 through January 15, 2027, subject to the Reporting Person's continued service to the Issuer through each vesting date. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock").

F2 · balance_after: Reflects shares of Common Stock beneficially owned by the Reporting Person as of the date hereof, excluding RSUs that do not vest within 60 days of this filing pursuant to Rule 13d-3(d)(1)(i).

Read SEC document
March 16, 2023 Filed Mar 21, 2023 10:15 UTC
Badawi PaulDirector · President and CEO
GrantStock Option (Right to Buy) · Derivative 225,700 $0.00 Strike: $9.78 $0.00
Disclosure

SEC source: 0000899243-23-009244 · doc4.xml · derivative · entry 2

Badawi Paul · CIK 0001870865 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 225,700

Underlying: Common Stock · 225,700 shares

Expires 2033-03-16

F3 · shares: Reflects a grant of stock options ("Options") made to the Reporting Person under the 2021 Plan. The Options vest and become exercisable in 48 equal monthly installments with the first installment vesting commencing on January 1, 2023 through January 1, 2027, subject to the Reporting Person's continued service to the Issuer through each vesting date.

F3 · derivative.exercise_date: Reflects a grant of stock options ("Options") made to the Reporting Person under the 2021 Plan. The Options vest and become exercisable in 48 equal monthly installments with the first installment vesting commencing on January 1, 2023 through January 1, 2027, subject to the Reporting Person's continued service to the Issuer through each vesting date.

Read SEC document
March 16, 2023 Filed Mar 21, 2023 10:15 UTC
Badawi PaulDirector · President and CEO
GrantCommon Stock 176,600 $0.00 $0.00
Disclosure

SEC source: 0000899243-23-009244 · doc4.xml · nonDerivative · entry 1

Badawi Paul · CIK 0001870865 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,278,481

F1 · shares: Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's 2021 Incentive Award Plan (the "2021 Plan"). The RSUs vest in four equal annual installments from January 15, 2024 through January 15, 2027, subject to the Reporting Person's continued service to the Issuer through each vesting date. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock").

F2 · balance_after: Reflects shares of Common Stock beneficially owned by the Reporting Person as of the date hereof, excluding RSUs that do not vest within 60 days of this filing pursuant to Rule 13d-3(d)(1)(i).

Read SEC document
March 16, 2023 Filed Mar 21, 2023 10:15 UTC
HAYDEN JEREMY B.Chief Legal Officer
GrantStock Option (Right to Buy) · Derivative 57,700 $0.00 Strike: $9.78 $0.00
Disclosure

SEC source: 0000899243-23-009245 · doc4.xml · derivative · entry 2

HAYDEN JEREMY B. · CIK 0001650737 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,700

Underlying: Common Stock · 57,700 shares

Expires 2033-03-16

F3 · shares: Reflects a grant of stock options ("Options") made to the Reporting Person under the 2021 Plan. The Options vest and become exercisable in 48 equal monthly installments with the first installment vesting commencing on January 1, 2023 through January 1, 2027, subject to the Reporting Person's continued service to the Issuer through each vesting date.

F3 · derivative.exercise_date: Reflects a grant of stock options ("Options") made to the Reporting Person under the 2021 Plan. The Options vest and become exercisable in 48 equal monthly installments with the first installment vesting commencing on January 1, 2023 through January 1, 2027, subject to the Reporting Person's continued service to the Issuer through each vesting date.

Read SEC document
March 16, 2023 Filed Mar 21, 2023 10:15 UTC
HAYDEN JEREMY B.Chief Legal Officer
GrantCommon Stock 45,100 $0.00 $0.00
Disclosure

SEC source: 0000899243-23-009245 · doc4.xml · nonDerivative · entry 1

HAYDEN JEREMY B. · CIK 0001650737 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,808

F1 · shares: Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's 2021 Incentive Award Plan (the "2021 Plan"). The RSUs vest in four equal annual installments from January 15, 2024 through January 15, 2027, subject to the Reporting Person's continued service to the Issuer through each vesting date. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock").

F2 · balance_after: Reflects shares of Common Stock beneficially owned by the Reporting Person as of the date hereof, excluding RSUs that do not vest within 60 days of this filing pursuant to Rule 13d-3(d)(1)(i).

Read SEC document
March 16, 2023 Filed Mar 21, 2023 10:15 UTC
Badawi DavidDirector · Chief Technology Officer
GrantStock Option (Right to Buy) · Derivative 50,000 $0.00 Strike: $9.78 $0.00
Disclosure

SEC source: 0000899243-23-009242 · doc4.xml · derivative · entry 2

Badawi David · CIK 0001870825 · Director · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2033-03-16

F3 · shares: Reflects a grant of stock options ("Options") made to the Reporting Person under the 2021 Plan. The Options vest and become exercisable in 48 equal monthly installments with the first installment vesting commencing on January 1, 2023 through January 1, 2027, subject to the Reporting Person's continued service to the Issuer through each vesting date.

F3 · derivative.exercise_date: Reflects a grant of stock options ("Options") made to the Reporting Person under the 2021 Plan. The Options vest and become exercisable in 48 equal monthly installments with the first installment vesting commencing on January 1, 2023 through January 1, 2027, subject to the Reporting Person's continued service to the Issuer through each vesting date.

Read SEC document
March 16, 2023 Filed Mar 21, 2023 10:15 UTC
Badawi DavidDirector · Chief Technology Officer
GrantCommon Stock 39,100 $0.00 $0.00
Disclosure

SEC source: 0000899243-23-009242 · doc4.xml · nonDerivative · entry 1

Badawi David · CIK 0001870825 · Director · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,485,790

F1 · shares: Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's 2021 Incentive Award Plan (the "2021 Plan"). The RSUs vest in four equal annual installments from January 15, 2024 through January 15, 2027, subject to the Reporting Person's continued service to the Issuer through each vesting date. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock").

F2 · balance_after: Reflects shares of Common Stock beneficially owned by the Reporting Person as of the date hereof, excluding RSUs that do not vest within 60 days of this filing pursuant to Rule 13d-3(d)(1)(i).

Read SEC document
March 16, 2023 Filed Mar 21, 2023 10:15 UTC
Rodberg JamesSee Remarks
GrantStock Option (Right to Buy) · Derivative 14,400 $0.00 Strike: $9.78 $0.00
Disclosure

SEC source: 0000899243-23-009241 · doc4.xml · derivative · entry 2

Rodberg James · CIK 0001961970 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,400

Underlying: Common Stock · 14,400 shares

Expires 2033-03-16

F3 · shares: Reflects a grant of stock options ("Options") made to the Reporting Person under the 2021 Plan. The Options vest and become exercisable in 48 equal monthly installments with the first installment vesting commencing on January 1, 2023 through January 1, 2027, subject to the Reporting Person's continued service to the Issuer through each vesting date.

F3 · derivative.exercise_date: Reflects a grant of stock options ("Options") made to the Reporting Person under the 2021 Plan. The Options vest and become exercisable in 48 equal monthly installments with the first installment vesting commencing on January 1, 2023 through January 1, 2027, subject to the Reporting Person's continued service to the Issuer through each vesting date.

Read SEC document
March 16, 2023 Filed Mar 21, 2023 10:15 UTC
Rodberg JamesSee Remarks
GrantCommon Stock 20,600 $0.00 $0.00
Disclosure

SEC source: 0000899243-23-009241 · doc4.xml · nonDerivative · entry 1

Rodberg James · CIK 0001961970 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 699

F1 · shares: Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's 2021 Incentive Award Plan (the "2021 Plan"). The RSUs vest in four equal annual installments from January 15, 2024 through January 15, 2027, subject to the Reporting Person's continued service to the Issuer through each vesting date. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock").

F2 · balance_after: Reflects shares of Common Stock beneficially owned by the Reporting Person as of the date hereof, excluding RSUs that do not vest within 60 days of this filing pursuant to Rule 13d-3(d)(1)(i).

Read SEC document
March 15, 2023 Filed Jun 12, 2023 21:41 UTC Tax withholdingCommon Stock 2,295 $9.08 $20,845.49
Disclosure

SEC source: 0000899243-23-015382 · doc4.xml · nonDerivative · entry 2

Larsen-Becker Brenda Jane · CIK 0001913647 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,679

F2 · shares: Reflects shares of Common Stock sold to cover the Reporting Person's tax liability in connection with the vesting of the RSUs underlying the 2022 RSU Grant.

F3 · price: Reflects the weighted average price at which the shares of Common Stock were sold. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Read SEC document
March 15, 2023 Filed Jun 12, 2023 21:41 UTC GrantCommon Stock 17,923 $0.00 $0.00
Disclosure

SEC source: 0000899243-23-015382 · doc4.xml · nonDerivative · entry 1

Larsen-Becker Brenda Jane · CIK 0001913647 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,974

F1 · shares: Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person on March 15, 2022 under the Issuer's Non-Employee Director Compensation Program (such grant, the "2022 RSU Grant"), as reported in Table II on the Reporting Person's Form 4 filed with the Securities and Exchange Commission on March 18, 2022. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). Of the RSUs awarded to the Reporting Person under the 2022 RSU Grant, one-third vested on March 15, 2023, and an additional one-third vests on each of March 15, 2024 and March 15, 2025, subject to the Reporting Person's continued service as a director on the Company's board of directors through each such vesting date.

Read SEC document
January 08, 2023 Filed Jan 10, 2023 23:43 UTC GrantCommon Stock 17,977 $0.00 $0.00
Disclosure

SEC source: 0000899243-23-001508 · doc4.xml · nonDerivative · entry 1

Fountain Tamara · CIK 0001902243 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · shares: Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person on under the Issuer's 2021 Incentive Award Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs shall vest and become exercisable in substantially equal installments on each of January 1, 2024, 2025, and 2026, subject to the Reporting Person's continued service as a director on the Company's board of directors through each such vesting date.

Read SEC document
January 04, 2023 Filed Jan 5, 2023 06:30 UTC
Park Sam BoongChief Operating Officer
Tax withholdingCommon Stock 2,393 $12.38 $29,622.95
Disclosure

SEC source: 0000899243-23-000827 · doc4.xml · nonDerivative · entry 5

Park Sam Boong · CIK 0001871706 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,424

F6 · shares: Reflects shares of Common Stock sold to cover the Reporting Person's tax liability in connection with the vesting of RSUs.

F7 · price: Reflects the weighted average price at which the shares were sold. The shares were sold in multiple transactions at prices ranging from $12.16 to $12.61, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
January 04, 2023 Filed Jan 5, 2023 11:30 UTC
Badawi PaulDirector · President and CEO
Tax withholdingCommon Stock 8,251 $12.21 $100,744.71
Disclosure

SEC source: 0000899243-23-000826 · doc4.xml · nonDerivative · entry 2

Badawi Paul · CIK 0001870865 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,278,481

F3 · shares: Reflects shares of Common Stock withheld by the Issuer to cover the Reporting Person's tax liability in connection with the vesting of RSUs.

F4 · price: Reflects the closing sale price of the Issuer's Common Stock as reported on The Nasdaq Global Select Market on December 30, 2022.

Read SEC document
January 04, 2023 Filed Jan 5, 2023 11:30 UTC
Selnick JesseChief Financial Officer
Tax withholdingCommon Stock 2,891 $12.38 $35,787.69
Disclosure

SEC source: 0000899243-23-000829 · doc4.xml · nonDerivative · entry 2

Selnick Jesse · CIK 0001870424 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 403,359

F3 · shares: Reflects shares of Common Stock sold to cover the Reporting Person's tax liability in connection with the vesting of RSUs.

F4 · price: Reflects the weighted average price at which the shares were sold. The shares were sold in multiple transactions at prices ranging from $12.16 to $12.61, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
January 04, 2023 Filed Jan 5, 2023 11:30 UTC
Badawi DavidDirector · Chief Technology Officer
Tax withholdingCommon Stock 2,431 $12.21 $29,682.51
Disclosure

SEC source: 0000899243-23-000828 · doc4.xml · nonDerivative · entry 2

Badawi David · CIK 0001870825 · Director · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,485,790

F3 · shares: Reflects shares of Common Stock withheld by the Issuer to cover the Reporting Person's tax liability in connection with the vesting of RSUs.

F4 · price: Reflects the closing sale price of the Issuer's Common Stock as reported on The Nasdaq Global Select Market on December 30, 2022.

Read SEC document
January 04, 2023 Filed Jan 5, 2023 11:30 UTC
HAYDEN JEREMY B.Chief Legal Officer
Tax withholdingCommon Stock 1,192 $12.38 $14,755.77
Disclosure

SEC source: 0000899243-23-000825 · doc4.xml · nonDerivative · entry 2

HAYDEN JEREMY B. · CIK 0001650737 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,808

F3 · shares: Reflects shares of Common Stock sold to cover the Reporting Person's tax liability in connection with the vesting of RSUs.

F4 · price: Reflects the weighted average price at which the shares were sold. The shares were sold in multiple transactions at prices ranging from $12.16 to $12.61, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
January 01, 2023 Filed Jan 5, 2023 06:30 UTC
Park Sam BoongChief Operating Officer
GrantCommon Stock 24,100 $0.00 $0.00
Disclosure

SEC source: 0000899243-23-000827 · doc4.xml · nonDerivative · entry 4

Park Sam Boong · CIK 0001871706 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,817

F4 · shares: Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person on February 9, 2022 under the Issuer's 2021 Incentive Award Plan (such grant, the "2022 RSU Grant"), as reported in Table II on the Reporting Person's Form 4 filed with the Securities and Exchange Commission on February 11, 2022. Of the RSUs awarded to the Reporting Person under the 2022 RSU Grant, 25% vested on January 1, 2023, and an additional 25% vest on each of January 1, 2024, 2025, and 2026. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The RSUs have no expiration date.

F5 · balance_after: Includes 6,025 shares of Common Stock issued in connection with the January 1, 2023 vesting of the 2022 RSU Grant.

Read SEC document
January 01, 2023 Filed Jan 5, 2023 11:30 UTC
Badawi PaulDirector · President and CEO
GrantCommon Stock 87,800 $0.00 $0.00
Disclosure

SEC source: 0000899243-23-000826 · doc4.xml · nonDerivative · entry 1

Badawi Paul · CIK 0001870865 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,286,732

F1 · shares: Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person on February 9, 2022 under the Issuer's 2021 Incentive Award Plan (such grant, the "2022 RSU Grant"), as reported in Table II on the Reporting Person's Form 4 filed with the Securities and Exchange Commission on February 11, 2022. Of the RSUs awarded to the Reporting Person under the 2022 RSU Grant, 25% vested on January 1, 2023, and an additional 25% vest on each of January 1, 2024, 2025, and 2026. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The RSUs have no expiration date.

F2 · balance_after: Includes 21,950 shares of Common Stock issued in connection with the January 1, 2023 vesting of the 2022 RSU Grant.

Read SEC document
January 01, 2023 Filed Jan 5, 2023 11:30 UTC
Selnick JesseChief Financial Officer
GrantCommon Stock 28,100 $0.00 $0.00
Disclosure

SEC source: 0000899243-23-000829 · doc4.xml · nonDerivative · entry 1

Selnick Jesse · CIK 0001870424 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 406,250

F1 · shares: Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person on February 9, 2022 under the Issuer's 2021 Incentive Award Plan (such grant, the "2022 RSU Grant"), as reported in Table II on the Reporting Person's Form 4 filed with the Securities and Exchange Commission on February 11, 2022. Of the RSUs awarded to the Reporting Person under the 2022 RSU Grant, 25% vested on January 1, 2023, and an additional 25% vest on each of January 1, 2024, 2025, and 2026. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The RSUs have no expiration date.

F2 · balance_after: Includes 7,025 shares of Common Stock issued in connection with the January 1, 2023 vesting of the 2022 RSU Grant.

Read SEC document
January 01, 2023 Filed Jan 5, 2023 11:30 UTC
Badawi DavidDirector · Chief Technology Officer
GrantCommon Stock 28,100 $0.00 $0.00
Disclosure

SEC source: 0000899243-23-000828 · doc4.xml · nonDerivative · entry 1

Badawi David · CIK 0001870825 · Director · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,488,221

F1 · shares: Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person on February 9, 2022 under the Issuer's 2021 Incentive Award Plan (such grant, the "RSU Grant"), as reported in Table II on the Reporting Person's Form 4 filed with the Securities and Exchange Commission on February 11, 2022. Of the RSUs awarded to the Reporting Person under the 2022 RSU Grant, 25% vested on January 1, 2023, and an additional 25% vest on each of January 1, 2024, 2025, and 2026. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The RSUs have no expiration date.

F2 · balance_after: Includes 7,025 shares of Common Stock issued in connection with the January 1, 2023 vesting of the 2022 RSU Grant.

Read SEC document
January 01, 2023 Filed Jan 5, 2023 11:30 UTC
HAYDEN JEREMY B.Chief Legal Officer
GrantCommon Stock 12,000 $0.00 $0.00
Disclosure

SEC source: 0000899243-23-000825 · doc4.xml · nonDerivative · entry 1

HAYDEN JEREMY B. · CIK 0001650737 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,000

F1 · shares: Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person on February 9, 2022 under the Issuer's 2021 Incentive Award Plan (such grant, the "2022 RSU Grant"), as reported in Table II on the Reporting Person's Form 4 filed with the Securities and Exchange Commission on February 11, 2022. Of the RSUs awarded to the Reporting Person under the 2022 RSU Grant, 25% vested on January 1, 2023, and an additional 25% vest on each of January 1, 2024, 2025, and 2026. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The RSUs have no expiration date.

F2 · balance_after: Includes 3,000 shares of Common Stock issued in connection with the January 1, 2023 vesting of the 2022 RSU Grant.

Read SEC document
November 18, 2022 Filed Jan 5, 2023 06:30 UTC
Park Sam BoongChief Operating Officer
GrantCommon Stock 3,128 $6.79 $21,245.38
Disclosure

SEC source: 0000899243-23-000827 · doc4.xml · nonDerivative · entry 3

Park Sam Boong · CIK 0001871706 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,792

F3 · shares: Reflects shares purchased under the Issuer's 2021 Employee Stock Purchase Plan.

Read SEC document
September 21, 2022 Filed Sep 23, 2022 20:05 UTC
Badawi DavidDirector · Chief Technology Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 40,000 $0.00 Strike: $0.23 $0.00
Disclosure

SEC source: 0000899243-22-031869 · doc4.xml · derivative · entry 2

Badawi David · CIK 0001870825 · Director · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 40,000 shares

Expires 2027-01-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The options are fully vested and exercisable.

Read SEC document
September 21, 2022 Filed Sep 23, 2022 20:05 UTC
Badawi DavidDirector · Chief Technology Officer
Exercise / conversionCommon Stock 40,000 $0.23 $9,200.00
Disclosure

SEC source: 0000899243-22-031869 · doc4.xml · nonDerivative · entry 1

Badawi David · CIK 0001870825 · Director · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,481,196

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 21, 2022 Filed Dec 30, 2025 21:11 UTC Amendment
Badawi DavidDirector · Chief Technology Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 40,000 $0.00 Strike: $0.23 $0.00
Disclosure

SEC source: 0001193125-25-337097 · ownership.xml · derivative · entry 2

Badawi David · CIK 0001870825 · Director · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,540

Underlying: Common Stock · 40,000 shares

Expires 2026-02-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The grant of stock options ("Options") made to the Reporting Person vested and became exercisable as to 25% of the underlying shares on January 1, 2017, and as to the remainder of such shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date, such that all such Options shall be fully vested and exercisable on January 1, 2020.

F3 · derivative.expiration_date: The original Form 4 filing identified the expiration date of the relevant Options as 01/08/2027. This amendment corrects the expiration date of the relevant Options to February 28, 2026.

F1 · balance_after: Includes 1,441,196 shares that were previously reported as beneficially owned on the Reporting Person's Form 3 filed on July 14, 2021, as well as 7,460 shares that were acquired by the Reporting Person upon exercise of options prior to the Issuer's completion of the Initial Public Offering in July 2021 that should have been included under Column 2 of Table I of the Form 3 but were inadvertently included as shares underlying options with an exercise price of $0.23 that expire on February 28, 2026 under Column 3 of Table II of the Form 3.

F4 · balance_after: Excludes the 7,460 shares that were previously inadvertently included as described in footnote (1) to this Form 4.

Read SEC document
July 06, 2022 Filed Jul 8, 2022 21:43 UTC
Hicks Mack H.Director · 10% owner
HH Sight LLC10% owner
OtherCommon Stock 1,717,140 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-025869 · doc4.xml · nonDerivative · entry 2

Hicks Mack H. · CIK 0001413224 · Director · 10% owner

HEP Partners LLC · CIK 0001810192 · 10% owner

HH Sight LLC · CIK 0001872481 · 10% owner

HH Sight Partners GP, L.P. · CIK 0001872472 · 10% owner

HH Sight Partners, L.P. · CIK 0001667542 · 10% owner

HH-IOP Partners, L.P. · CIK 0001667541 · 10% owner

HICKS THOMAS O · CIK 0000938201 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 0

F7 · kind: Represents a pro rata distribution in-kind of all the shares formerly held by HH-IOP to its partners (the "HH-IOP Distribution"). As a result of both the HH Sight Distribution and the HH-IOP Distribution, in addition to HH Sight Partners, each of HH-IOP, the GP, the GP of the GP, HEP and Thomas O. Hicks will no longer be a reporting person.

F2 · ownership.nature: This statement is jointly filed by and on behalf of each of Mack H. Hicks, Thomas O. Hicks, HH Sight Partners, HH-IOP Partners, L.P. ("HH-IOP"), HH Sight Partners GP, L.P. (the "GP"), HH Sight LLC (the "GP of GP"), and HEP Partners LLC ("HEP"). HH Sight Partners, HH-IOP, and Mack H. Hicks (individually, as Trustee of the MHH 2016 Descendants Trust, and as the ultimate owner and control person of MHH Ventures Ltd.) are the direct beneficial owners of the securities covered by this statement.

F3 · ownership.nature: The GP is the general partner of, and may be deemed to beneficially own securities owned by, each of HH Sight Partners and HH-IOP. The GP of the GP is the general partner of, and may be deemed to beneficially own securities owned by, the GP. Mack H. Hicks and Thomas O. Hicks are the co-managers of, and may each be deemed to beneficially own securities owned by, the GP of the GP. HEP is the investment manager of, and may be deemed to beneficially own securities owned by, each of HH Sight Partners and HH-IOP. Thomas O. Hicks is the Chairman, President, and Chief Executive Officer of, and may be deemed to beneficially own securities owned by, HEP.

F4 · ownership.nature: Each reporting person states that neither the filing of this statement nor anything herein shall be deemed an admission that such person is, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise, the beneficial owner of any securities covered by this statement. Each reporting person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of such person in such securities.

F5 · ownership.nature: Each reporting person may be deemed to be a member of a group with respect to the Issuer or securities of the Issuer for purposes of Section 13(d) or 13(g) of the Exchange Act. Each reporting person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section 13(d) or 13(g) of the Exchange Act or any other purpose, a member of a group with respect to the Issuer or securities of the Issuer.

F8 · ownership.nature: Represents common stock directly held by HH-IOP.

Read SEC document
July 06, 2022 Filed Jul 8, 2022 21:43 UTC
Hicks Mack H.Director · 10% owner
HH Sight LLC10% owner
OtherCommon Stock 2,669,530 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-025869 · doc4.xml · nonDerivative · entry 1

Hicks Mack H. · CIK 0001413224 · Director · 10% owner

HEP Partners LLC · CIK 0001810192 · 10% owner

HH Sight LLC · CIK 0001872481 · 10% owner

HH Sight Partners GP, L.P. · CIK 0001872472 · 10% owner

HH Sight Partners, L.P. · CIK 0001667542 · 10% owner

HH-IOP Partners, L.P. · CIK 0001667541 · 10% owner

HICKS THOMAS O · CIK 0000938201 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 0

F1 · kind: Represents a pro rata distribution in-kind of all the shares formerly held by HH Sight Partners, L.P. ("HH Sight Partners") to its partners (the "HH Sight Distribution"). As a result of the HH Sight Distribution, HH Sight Partners will no longer be a reporting person.

F2 · ownership.nature: This statement is jointly filed by and on behalf of each of Mack H. Hicks, Thomas O. Hicks, HH Sight Partners, HH-IOP Partners, L.P. ("HH-IOP"), HH Sight Partners GP, L.P. (the "GP"), HH Sight LLC (the "GP of GP"), and HEP Partners LLC ("HEP"). HH Sight Partners, HH-IOP, and Mack H. Hicks (individually, as Trustee of the MHH 2016 Descendants Trust, and as the ultimate owner and control person of MHH Ventures Ltd.) are the direct beneficial owners of the securities covered by this statement.

F3 · ownership.nature: The GP is the general partner of, and may be deemed to beneficially own securities owned by, each of HH Sight Partners and HH-IOP. The GP of the GP is the general partner of, and may be deemed to beneficially own securities owned by, the GP. Mack H. Hicks and Thomas O. Hicks are the co-managers of, and may each be deemed to beneficially own securities owned by, the GP of the GP. HEP is the investment manager of, and may be deemed to beneficially own securities owned by, each of HH Sight Partners and HH-IOP. Thomas O. Hicks is the Chairman, President, and Chief Executive Officer of, and may be deemed to beneficially own securities owned by, HEP.

F4 · ownership.nature: Each reporting person states that neither the filing of this statement nor anything herein shall be deemed an admission that such person is, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise, the beneficial owner of any securities covered by this statement. Each reporting person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of such person in such securities.

F5 · ownership.nature: Each reporting person may be deemed to be a member of a group with respect to the Issuer or securities of the Issuer for purposes of Section 13(d) or 13(g) of the Exchange Act. Each reporting person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section 13(d) or 13(g) of the Exchange Act or any other purpose, a member of a group with respect to the Issuer or securities of the Issuer.

F6 · ownership.nature: Represents common stock directly held by HH Sight Partners.

Read SEC document
June 08, 2022 Filed Aug 5, 2022 20:14 UTC GrantRestricted Stock Units · Derivative 11,940 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-027828 · doc4.xml · derivative · entry 1

Encrantz Staffan · CIK 0001870875 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,940

Underlying: Common Stock · 11,940 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.

F2 · derivative.exercise_date: The RSUs vest on the earlier of (i) June 8, 2023 and (ii) one day prior to the Company's 2023 annual meeting of shareholders, subject to the Reporting Person's continued service with the Issuer through such vesting date. The RSUs have no expiration date.

F2 · derivative.expiration_date: The RSUs vest on the earlier of (i) June 8, 2023 and (ii) one day prior to the Company's 2023 annual meeting of shareholders, subject to the Reporting Person's continued service with the Issuer through such vesting date. The RSUs have no expiration date.

Read SEC document
June 08, 2022 Filed Aug 5, 2022 20:11 UTC GrantRestricted Stock Units · Derivative 11,940 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-027823 · doc4.xml · derivative · entry 1

Zurbay Donald · CIK 0001341608 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,940

Underlying: Common Stock · 11,940 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.

F2 · derivative.exercise_date: The RSUs vest on the earlier of (i) June 8, 2023 and (ii) one day prior to the Company's 2023 annual meeting of shareholders, subject to the Reporting Person's continued service with the Issuer through such vesting date.. The RSUs have no expiration date.

F2 · derivative.expiration_date: The RSUs vest on the earlier of (i) June 8, 2023 and (ii) one day prior to the Company's 2023 annual meeting of shareholders, subject to the Reporting Person's continued service with the Issuer through such vesting date.. The RSUs have no expiration date.

Read SEC document
June 08, 2022 Filed Aug 5, 2022 20:11 UTC
Hicks Mack H.Director · 10% owner
GrantRestricted Stock Units · Derivative 11,940 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-027824 · doc4.xml · derivative · entry 1

Hicks Mack H. · CIK 0001413224 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,940

Underlying: Common Stock · 11,940 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.

F2 · derivative.exercise_date: The RSUs vest on the earlier of (i) June 8, 2023 and (ii) one day prior to the Company's 2023 annual meeting of shareholders, subject to the Reporting Person's continued service with the Issuer through such vesting date. The RSUs have no expiration date.

F2 · derivative.expiration_date: The RSUs vest on the earlier of (i) June 8, 2023 and (ii) one day prior to the Company's 2023 annual meeting of shareholders, subject to the Reporting Person's continued service with the Issuer through such vesting date. The RSUs have no expiration date.

Read SEC document
June 08, 2022 Filed Aug 5, 2022 20:08 UTC GrantRestricted Stock Units · Derivative 11,940 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-027818 · doc4.xml · derivative · entry 1

Rogers Erica J. · CIK 0001769940 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,940

Underlying: Common Stock · 11,940 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.

F2 · derivative.exercise_date: The RSUs vest on the earlier of (i) June 8, 2023 and (ii) one day prior to the Company's 2023 annual meeting of shareholders, subject to the Reporting Person's continued service with the Issuer through such vesting date. The RSUs have no expiration date.

F2 · derivative.expiration_date: The RSUs vest on the earlier of (i) June 8, 2023 and (ii) one day prior to the Company's 2023 annual meeting of shareholders, subject to the Reporting Person's continued service with the Issuer through such vesting date. The RSUs have no expiration date.

Read SEC document
June 08, 2022 Filed Aug 5, 2022 20:12 UTC GrantRestricted Stock Units · Derivative 11,940 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-027825 · doc4.xml · derivative · entry 1

Schroeder Valeska · CIK 0001870428 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,940

Underlying: Common Stock · 11,940 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.

F2 · derivative.exercise_date: The RSUs vest on the earlier of (i) June 8, 2023 and (ii) one day prior to the Company's 2023 annual meeting of shareholders, subject to the Reporting Person's continued service with the Issuer through such vesting date. The RSUs have no expiration date.

F2 · derivative.expiration_date: The RSUs vest on the earlier of (i) June 8, 2023 and (ii) one day prior to the Company's 2023 annual meeting of shareholders, subject to the Reporting Person's continued service with the Issuer through such vesting date. The RSUs have no expiration date.

Read SEC document
May 17, 2022 Filed May 18, 2022 01:40 UTC
Encrantz StaffanDirector · 10% owner
PurchaseCommon Stock 250,000 $8.49 $2,123,725.00
Disclosure

SEC source: 0000899243-22-018500 · doc4.xml · nonDerivative · entry 3

Encrantz Staffan · CIK 0001870875 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 551,802

F2 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (4) and (5).

F5 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.155 to $8.73 per share, inclusive.

F3 · ownership.nature: These shares are held of record by the 1997 Staffan Encrantz and Margareta Encrantz Revocable Trust (the "Trust"). The Reporting Person is a trustee of the Trust and may be deemed to beneficially own the shares held by the Trust. The Reporting Person disclaims beneficial ownership of the shares held by the Trust (and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such shares for purposes of Section 16 or for any other purpose), except to the extent of his pecuniary interest therein, if any.

Read SEC document
May 16, 2022 Filed May 18, 2022 01:40 UTC
Encrantz StaffanDirector · 10% owner
PurchaseCommon Stock 300,000 $8.20 $2,460,000.00
Disclosure

SEC source: 0000899243-22-018500 · doc4.xml · nonDerivative · entry 2

Encrantz Staffan · CIK 0001870875 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 301,802

F2 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (4) and (5).

F4 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.025 to $8.45 per share, inclusive.

F3 · ownership.nature: These shares are held of record by the 1997 Staffan Encrantz and Margareta Encrantz Revocable Trust (the "Trust"). The Reporting Person is a trustee of the Trust and may be deemed to beneficially own the shares held by the Trust. The Reporting Person disclaims beneficial ownership of the shares held by the Trust (and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such shares for purposes of Section 16 or for any other purpose), except to the extent of his pecuniary interest therein, if any.

Read SEC document
May 13, 2022 Filed May 18, 2022 01:40 UTC
Encrantz StaffanDirector · 10% owner
PurchaseCommon Stock 1,802 $7.98 $14,381.94
Disclosure

SEC source: 0000899243-22-018500 · doc4.xml · nonDerivative · entry 1

Encrantz Staffan · CIK 0001870875 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 1,802

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.91 to $8.00 per share, inclusive.

F2 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (4) and (5).

F3 · ownership.nature: These shares are held of record by the 1997 Staffan Encrantz and Margareta Encrantz Revocable Trust (the "Trust"). The Reporting Person is a trustee of the Trust and may be deemed to beneficially own the shares held by the Trust. The Reporting Person disclaims beneficial ownership of the shares held by the Trust (and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such shares for purposes of Section 16 or for any other purpose), except to the extent of his pecuniary interest therein, if any.

Read SEC document
May 13, 2022 Filed May 17, 2022 20:05 UTC
Selnick JesseChief Financial Officer
PurchaseCommon Stock 5,000 $8.28 $41,400.00
Disclosure

SEC source: 0000899243-22-018389 · doc4.xml · nonDerivative · entry 1

Selnick Jesse · CIK 0001870424 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 249,225

F1 · ownership.direct: The Reporting Person previously reported indirect beneficial ownership of 2,219,568 shares of Common Stock held of record by Sight Sciences Angels, LP ("Sight Sciences Angels"). Sight Sciences Angels subsequently distributed such shares of Common Stock to its partners, resulting in the Reporting Person directly owning the shares of Common Stock in which he previously had an indirect pecuniary interest. Such change in ownership was exempt from reporting pursuant to Rule 16a-13.

Read SEC document
May 11, 2022 Filed May 23, 2022 21:44 UTC
Selnick JesseChief Financial Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 30,000 $0.00 Strike: $0.62 $0.00
Disclosure

SEC source: 0000899243-22-019270 · doc4.xml · derivative · entry 4

Selnick Jesse · CIK 0001870424 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 30,000 shares

Expires 2029-04-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option vests in 48 substantially equal monthly installments beginning on March 18, 2019.

Read SEC document
May 11, 2022 Filed May 23, 2022 21:44 UTC
Selnick JesseChief Financial Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 120,000 $0.00 Strike: $0.35 $0.00
Disclosure

SEC source: 0000899243-22-019270 · doc4.xml · derivative · entry 3

Selnick Jesse · CIK 0001870424 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 120,000 shares

Expires 2028-02-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option vested as to 25% of the underlying shares on January 23, 2019 and in 36 equal monthly installments thereafter.

Read SEC document
May 11, 2022 Filed May 23, 2022 21:44 UTC
Selnick JesseChief Financial Officer
Exercise / conversionCommon Stock 30,000 $0.62 $18,600.00
Disclosure

SEC source: 0000899243-22-019270 · doc4.xml · nonDerivative · entry 2

Selnick Jesse · CIK 0001870424 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 399,225

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 5,000 shares acquired on May 13, 2022 reported on a Form 4 filed on May 17, 2022.

Read SEC document
May 11, 2022 Filed May 23, 2022 21:44 UTC
Selnick JesseChief Financial Officer
Exercise / conversionCommon Stock 120,000 $0.35 $42,000.00
Disclosure

SEC source: 0000899243-22-019270 · doc4.xml · nonDerivative · entry 1

Selnick Jesse · CIK 0001870424 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 369,225

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 5,000 shares acquired on May 13, 2022 reported on a Form 4 filed on May 17, 2022.

Read SEC document
March 25, 2022 Filed Jan 5, 2023 06:30 UTC
Park Sam BoongChief Operating Officer
Exercise / conversionCommon Stock 3,666 $1.96 $7,185.36
Disclosure

SEC source: 0000899243-23-000827 · doc4.xml · nonDerivative · entry 2

Park Sam Boong · CIK 0001871706 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,664

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · shares: Reflects the exercise of stock options awarded under the Issuer's equity incentive plan.

Read SEC document
March 15, 2022 Filed Mar 18, 2022 21:47 UTC GrantRestricted Stock Units · Derivative 17,923 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-011607 · doc4.xml · derivative · entry 1

Larsen-Becker Brenda Jane · CIK 0001913647 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,923

Underlying: Common Stock · 17,923 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.

F2 · derivative.exercise_date: The RSUs vest in three substantially equal annual installments beginning on March 15, 2023, subject to the Reporting Person's continued service to the Issuer through each such vesting date. The RSUs have no expiration date.

F2 · derivative.expiration_date: The RSUs vest in three substantially equal annual installments beginning on March 15, 2023, subject to the Reporting Person's continued service to the Issuer through each such vesting date. The RSUs have no expiration date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.